Literature DB >> 27530778

Thermodynamic Analysis of the Geldanamycin-Hsp90 Interaction in a Whole Cell Lysate Using a Mass Spectrometry-Based Proteomics Approach.

Yingrong Xu1,2, M Ariel Geer Wallace3,2, Michael C Fitzgerald4.   

Abstract

Geldanamycin is a natural product with well-established and potent anti-cancer activities. Heat shock protein 90 (Hsp90) is the known target of geldanamycin, which directly binds to Hsp90's N-terminal ATP binding domain and inhibits Hsp90's ATPase activity. The affinity of geldanamycin for Hsp90 has been measured in multiple studies. However, there have been large discrepancies between the reported dissociation constants (i.e., Kd values), which have ranged from low nanomolar to micromolar. Here the stability of proteins from rates of oxidation (SPROX) technique was used in combination with an isobaric mass tagging strategy to measure the binding affinity of geldanamycin to unpurified Hsp90 in an MCF-7 cell lysate. The Kd values determined here were dependent on how long geldanamycin was equilibrated with the lysate prior to SPROX analysis. The Kd values determined using equilibration times of 0.5 and 24 h were 1 and 0.03 μM, respectively. These Kd values, which are similar to those previously reported in a geldanamycin-Hsp90 binding study that involved the use of a fluorescently labeled geldanamycin analogue, establish that the slow-tight binding behavior previously observed for the fluorescently labeled geldanamycin analogue is not an artifact of the fluorescent label, but rather an inherent property of the geldanamycin-Hsp90 binding interaction. The slow-tight binding property of this complex may be related to time-dependent conformational changes in Hsp90 and/or to time-dependent chemical changes in geldanamycin, both of which have been previously proposed to explain the slow-tight binding behavior of the geldanamycin-Hsp90 complex. Graphical Abstract ᅟ.

Entities:  

Keywords:  Binding affinity; Chemical denaturation; Covalent labeling; Heat shock protein 90; Isobaric mass tags; Protein folding; Protein–ligand binding; Thermodynamic stability

Mesh:

Substances:

Year:  2016        PMID: 27530778     DOI: 10.1007/s13361-016-1457-2

Source DB:  PubMed          Journal:  J Am Soc Mass Spectrom        ISSN: 1044-0305            Impact factor:   3.109


  34 in total

1.  Dihydroquinone ansamycins: toward resolving the conflict between low in vitro affinity and high cellular potency of geldanamycin derivatives.

Authors:  Anna C Maroney; Juan J Marugan; Tara M Mezzasalma; Alexander N Barnakov; Thomas A Garrabrant; Larry E Weaner; William J Jones; Ludmila A Barnakova; Holly K Koblish; Matthew J Todd; John A Masucci; Ingrid C Deckman; Robert A Galemmo; Dana L Johnson
Journal:  Biochemistry       Date:  2006-05-02       Impact factor: 3.162

2.  A biochemical rationale for the anticancer effects of Hsp90 inhibitors: slow, tight binding inhibition by geldanamycin and its analogues.

Authors:  Lata T Gooljarsingh; Christine Fernandes; Kang Yan; Hong Zhang; Michael Grooms; Kyung Johanson; Robert H Sinnamon; Robert B Kirkpatrick; John Kerrigan; Tia Lewis; Marc Arnone; Alastair J King; Zhihong Lai; Robert A Copeland; Peter J Tummino
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-09       Impact factor: 11.205

3.  Crystal structure of an Hsp90-geldanamycin complex: targeting of a protein chaperone by an antitumor agent.

Authors:  C E Stebbins; A A Russo; C Schneider; N Rosen; F U Hartl; N P Pavletich
Journal:  Cell       Date:  1997-04-18       Impact factor: 41.582

4.  Evaluation of effect of triterpenes and limonoids on cell growth, cell cycle and apoptosis in human tumor cell line.

Authors:  Cristiane M Cazal; Kantima Choosang; Vanessa Gisele P Severino; Marcio S Soares; Andre Lucio F Sarria; Joao B Fernandes; Maria Fatima G F Silva; Paulo Cezar Vieira; Pannee Pakkong; Gabriela M Almeida; M Helena Vasconcelos; Maria S J Nascimento; Madalena M M Pinto
Journal:  Anticancer Agents Med Chem       Date:  2010-12       Impact factor: 2.505

5.  Investigating the protein-protein interactions of the yeast Hsp90 chaperone system by two-hybrid analysis: potential uses and limitations of this approach.

Authors:  Stefan H Millson; Andrew W Truman; Francis Wolfram; Victoria King; Barry Panaretou; Chrisostomos Prodromou; Laurence H Pearl; Peter W Piper
Journal:  Cell Stress Chaperones       Date:  2004       Impact factor: 3.667

6.  Thermodynamic analysis of protein stability and ligand binding using a chemical modification- and mass spectrometry-based strategy.

Authors:  Graham M West; Liangjie Tang; Michael C Fitzgerald
Journal:  Anal Chem       Date:  2008-05-06       Impact factor: 6.986

7.  Mechanistic studies on Hsp90 inhibition by ansamycin derivatives.

Authors:  S C Onuoha; S R Mukund; E T Coulstock; B Sengerovà; J Shaw; S H McLaughlin; S E Jackson
Journal:  J Mol Biol       Date:  2007-06-29       Impact factor: 5.469

Review 8.  Targeting heat-shock-protein 90 (Hsp90) by natural products: geldanamycin, a show case in cancer therapy.

Authors:  Jana Franke; Simone Eichner; Carsten Zeilinger; Andreas Kirschning
Journal:  Nat Prod Rep       Date:  2013-08-12       Impact factor: 13.423

9.  Characterization of the Saccharomyces cerevisiae ATP-Interactome using the iTRAQ-SPROX Technique.

Authors:  M Ariel Geer; Michael C Fitzgerald
Journal:  J Am Soc Mass Spectrom       Date:  2015-11-03       Impact factor: 3.109

10.  The hexameric structures of human heat shock protein 90.

Authors:  Cheng-Chung Lee; Ta-Wei Lin; Tzu-Ping Ko; Andrew H-J Wang
Journal:  PLoS One       Date:  2011-05-25       Impact factor: 3.240

View more
  6 in total

1.  Comparative Analysis of Mass-Spectrometry-Based Proteomic Methods for Protein Target Discovery Using a One-Pot Approach.

Authors:  Aurora Cabrera; Nancy Wiebelhaus; Baiyi Quan; Renze Ma; He Meng; Michael C Fitzgerald
Journal:  J Am Soc Mass Spectrom       Date:  2019-11-22       Impact factor: 3.109

2.  Discovery of Tamoxifen and N-Desmethyl Tamoxifen Protein Targets in MCF-7 Cells Using Large-Scale Protein Folding and Stability Measurements.

Authors:  Ryenne N Ogburn; Lorrain Jin; He Meng; Michael C Fitzgerald
Journal:  J Proteome Res       Date:  2017-10-11       Impact factor: 4.466

3.  Global analysis of methionine oxidation provides a census of folding stabilities for the human proteome.

Authors:  Ethan J Walker; John Q Bettinger; Kevin A Welle; Jennifer R Hryhorenko; Sina Ghaemmaghami
Journal:  Proc Natl Acad Sci U S A       Date:  2019-03-07       Impact factor: 11.205

Review 4.  An update of label-free protein target identification methods for natural active products.

Authors:  Zhao Cui; Caifeng Li; Peng Chen; Hongjun Yang
Journal:  Theranostics       Date:  2022-01-24       Impact factor: 11.556

Review 5.  Modulating Chaperone-Mediated Autophagy and Its Clinical Applications in Cancer.

Authors:  Virginie Hubert; Sebastian Weiss; Andrew Jackson Rees; Renate Kain
Journal:  Cells       Date:  2022-08-17       Impact factor: 7.666

Review 6.  Assay design and development strategies for finding Hsp90 inhibitors and their role in human diseases.

Authors:  Monimoy Banerjee; Ishita Hatial; Bradley M Keegan; Brian S J Blagg
Journal:  Pharmacol Ther       Date:  2020-11-24       Impact factor: 12.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.